These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19262541)

  • 21. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 22. Intermittent enteral feeding: the influence on respiratory and digestive tract colonization in mechanically ventilated intensive-care-unit patients.
    Bonten MJ; Gaillard CA; van der Hulst R; de Leeuw PW; van der Geest S; Stobberingh EE; Soeters PB
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):394-9. PubMed ID: 8756812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
    Heidelbaugh JJ; Metz DC; Yang YX
    Int J Clin Pract; 2012 Jun; 66(6):582-91. PubMed ID: 22607510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GORD patients on chronic acid suppressive medication: a population-average psychological state.
    van der Velden A; De Wit N; Quartero AO; Grobbee DE; Numans ME
    Scand J Gastroenterol; 2009; 44(3):380-2. PubMed ID: 18819038
    [No Abstract]   [Full Text] [Related]  

  • 30. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
    Malcolm WF; Cotten CM
    Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection.
    Cat TB; Charash W; Hebert J; Marden BT; Corbett SM; Ahern J; Rebuck JA
    Ann Pharmacother; 2008 Feb; 42(2):185-91. PubMed ID: 18212256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acid inhibition leads to vitamin b12 deficiency].
    Zwicker J
    Med Monatsschr Pharm; 2014 May; 37(5):190-1. PubMed ID: 24908938
    [No Abstract]   [Full Text] [Related]  

  • 35. Rebound acid hypersecretion.
    McColl KE
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):201. PubMed ID: 15125688
    [No Abstract]   [Full Text] [Related]  

  • 36. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
    Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
    Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study Questions Use of Acid Suppressors to Curb Mild Infant Reflux.
    Lyon J
    JAMA; 2017 Oct; 318(15):1427-1428. PubMed ID: 28973122
    [No Abstract]   [Full Text] [Related]  

  • 38. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
    Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
    J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uses and abuses of acid-suppression therapy in children.
    Hassall E
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S8-9. PubMed ID: 22235449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.